M’kacher et al., 2003; [45] |
In vitro & in vivo
|
Adult patients (n = 10) |
Translocations, dicentrics, rings, insertions and acentric fragments of painted chromosomes in metaphase and chromosome fragments in interphase (PCC) |
FISH (chromosome DNA probes 1, 3, 4) |
In vivo: 0.057 Gy; in vitro: 0.05, 0.1, 0.2 Gy |
|
Significant increase in chromosomal fragments (PCC) but not chromosome aberrations in metaphase |
Stephan et al., 2007; [39] |
In vivo |
Pediatric patients (n = 10) |
Dicentric (dic) & excess acentrics (ace) |
Fluorescence plus Giemsa (FPG) staining |
Mean dose to blood: 12.9 mGy |
>20 000 cells (average: 1000 cells/subject) |
Yes (only in patients <10 years old) |
Jost et al., 2009; [28] |
In vitro |
|
Dicentric |
Fluorescence plus Giemsa (FPG) staining |
0.025, 0.05, 0.1, 1 Gy |
>1000 metaphase/subject (0, 0.025, 0.05, 0.1 Gy); >200 metaphase for subjects after 1 Gy IR |
Yes |
Golfier et al., 2009; [61] |
In vitro |
|
Dicentric |
Fluorescence plus Giemsa (FPG) staining |
0.025, 0.05, 0.1, 1 Gy |
>1000 metaphase/subject (0, 0.025, 0.05, 0.1 Gy); >200 metaphase for subjects after 1 Gy IR |
Yes |
Abe et al., 2015; [41] |
In vivo |
Adult patients (n = 10) |
Dicentric |
Giemsa staining & PNA-FISH |
5.78–60.27 mSv: mean 24.24 mSv |
2000 metaphase/subject |
Yes |
Kanagaraj et al., 2015 [40] |
In vivo |
Adult patients (contrast scan: n = 14; brain plain scan: n = 13) |
Chromosome aberrations (dicentric, chromosome/chromatid break) & MN |
Giemsa staining |
Eye: 2~520 mGy; forehead: 0.84–210 mGy; thyroid: 1.79~ 185 |
250–300 metaphase/subject (chromosome aberrations); 1000 binucleated cells (MN) |
Yes |
Abe et al., 2016; [62] |
In vivo |
Adult patients (n = 12) |
Translocation |
FISH (chromosome painting DNA probes 1, 2, 4) |
5.78–60.27 mSv: mean 24.24 mSv |
>5000 metaphase/subject |
No significant increase in translocation after CT scan |